Shareholding disclosure

Novartis Pharma AG

Declared position

67.46%

Threshold

Crossed upwards

Timeline

Published

29.07.2008

Transaction

21.07.2008

Transfer date

21.07.2008

Voting rights breakdown

Voting rights acquired67.46%

Voting rights sold0%

Below threshold0%

Notice details

CategoryGroup of shareholders

ExchangeXSWX

Notification ID

T6470D6225

Beneficial owner

Novartis Pharma AG

Declared address

Novartis Pharma AG, Basel

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Novartis Pharma AG

Speedel Holding Ltd.29.07.2008T6470D6225

Disclosure summary

Novartis Pharma AG disclosed a holding in Speedel Holding Ltd. on the acquisition side, published by SIX Exchange Regulation on 29.07.2008, at 67.46% of voting rights. Notice category: Group of shareholders.

Disclosed position

67.46%

Voting rights acquired

Voting rights acquired67.46%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Novartis Pharma AG disclosed a holding in Speedel Holding Ltd., published on 29.07.2008.

Publication date29.07.2008

Transaction date21.07.2008

Transfer date21.07.2008

Issuing companySpeedel Holding Ltd.

Beneficial ownerNovartis Pharma AG

Declared addressNovartis Pharma AG, Basel

CategoryGroup of shareholders

Voting rights acquired67.46%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDT6470D6225

Commercial register

CHE-106.052.527

Registered

Zefix record

Source: SIX Exchange Regulation · Publication date: 29.07.2008

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open